Ward 21 CRS Hosts BIYELA Protocol Training

10 May 2024

On 10 May 2024, the Wits RHI Research Team at Ward 21 CRS, led by Prof. Sinead Delany-Moretlwe (Director of Research at Wits RHI), welcomed visitors including Dr. Lori Newman (Deputy Director STI & Gynecology) and Dr. Lyou-Fu Ma (Portfolio and Platform Lead) from the Bill & Melinda Gates Foundation, along with Prof. Connie Cellum and her team from the University of Washington. This site visit provided a practical overview of the upcoming Biyela study, a Phase 3 randomized, double-blinded, placebo-controlled trial. The Biyela study aims to assess the efficacy of the Meningococcal Serogroup B Vaccine (Bexsero) in preventing gonococcal infection among individuals born female in South Africa.

BIYELA Protocol Training Group: The Wits RHI Research Team and guests gather during the site visit to Ward 21 CRS for an overview of the upcoming Biyela study.


Stay up to date

Get updates on news, resources, events and happenings from Wits RHI.